Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Asynchronous telemedicine for acne treatment is effective and improves access and productivity.

Six African American women experienced hair loss after switching to a new HIV medication.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Ruxolitinib helped a patient with alopecia areata regrow hair.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

HGF combined with ADA is highly accurate for diagnosing tuberculous pleural effusion, especially in younger females.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

New probes were created to effectively measure specific enzymes involved in fat metabolism, which could help develop new drugs.

AcD scaffolds improve tissue repair and regeneration by combining stem cells with a supportive matrix.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

AMT is the best surfactant for hair and scalp care.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

The protein AtRXR3 limits root hair growth in Arabidopsis, affecting phosphorus uptake.

A specific gene variant is linked to severe insulin resistance and hormone imbalance in a teenage girl.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

The new microrhizotron tool effectively observes and measures pepper plant roots non-destructively.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.